TELA (TELA Bio, Inc. Common Stock)
Insider Trading Activity
Every open-market purchase and sale reported by TELA officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-19 | Heather C Getz | Chief Executive Officer | Buy | — | — |
| 2026-08-17 | Heather C Getz | Chief Executive Officer | Buy | — | — |
| 2026-08-05 | Heather C Getz | Chief Executive Officer | A | — | — |
| 2026-07-17 | William J. Plovanic | Director | A | — | — |
| 2026-07-17 | Joseph H Capper | Director | A | — | — |
| 2026-06-11 | Joseph H Capper | Director | A | — | — |
| 2026-06-11 | William J. Plovanic | Director | A | — | — |
| 2026-06-11 | PAUL THOMAS | Director | A | — | — |
| 2026-06-11 | GUIDO J NEELS | Director | A | — | — |
| 2026-06-11 | Betty Jo Rocchio | Director | A | — | — |
| 2026-06-11 | GUY P NOHRA | Director | A | — | — |
| 2026-02-24 | Megan Smeykal | Chief Accounting Officer | MIXED | — | — |
| 2026-02-24 | Gregory A. Firestone | Chief Business Officer | MIXED | — | — |
| 2026-02-24 | Roberto Cuca | COO and CFO | MIXED | — | — |
| 2026-02-24 | Jeffrey Blizard | President | A | — | — |
| 2026-02-24 | ANTONY KOBLISH | Chief Executive Officer | MIXED | — | — |
| 2026-02-24 | Paul Talmo | Chief Technology Officer | MIXED | — | — |
| 2025-11-17 | EW HEALTHCARE PARTNERS FUND 2-A, L.P. | 10%+ Owner | Buy | — | — |
| 2025-11-03 | William J. Plovanic | Director | A | — | — |
| 2025-10-10 | Betty Jo Rocchio | Director | A | — | — |
| 2025-08-05 | Gregory A. Firestone | Chief Commercial Officer | F | — | — |
| 2025-06-02 | Jeffrey Blizard | President | A | — | — |
| 2025-05-30 | Vincent J Burgess | Director | A | — | — |
| 2025-05-30 | Jeffrey Blizard | Director | A | — | — |
| 2025-05-30 | LISA N COLLERAN | Director | A | — | — |
| 2025-05-30 | Federica F. O'Brien | Director | A | — | — |
| 2025-05-30 | Kurt Azarbarzin | Director | A | — | — |
| 2025-05-30 | DOUGLAS G EVANS | Director | A | — | — |
| 2025-04-02 | Megan Smeykal | Chief Accounting Officer | F | — | — |
| 2025-04-02 | Paul Talmo | Chief Technology Officer | F | — | — |
| 2025-04-02 | ANTONY KOBLISH | Chief Executive Officer | F | — | — |
| 2025-04-02 | Gregory A. Firestone | Chief Commercial Officer | F | — | — |
| 2025-02-25 | Roberto Cuca | COO and CFO | MIXED | — | — |
| 2025-02-25 | Paul Talmo | Chief Technology Officer | MIXED | — | — |
| 2025-02-25 | Gregory A. Firestone | Chief Commercial Officer | MIXED | — | — |
| 2025-02-25 | Megan Smeykal | Chief Accounting Officer | F | — | — |
| 2025-02-25 | ANTONY KOBLISH | Chief Executive Officer | MIXED | — | — |
| 2025-02-21 | Megan Smeykal | Chief Accounting Officer | A | — | — |
| 2024-10-24 | Gregory A. Firestone | Chief Commercial Officer | Buy | — | — |
| 2024-10-24 | Paul Talmo | Chief Technology Officer | Buy | — | — |
| 2024-10-24 | ANTONY KOBLISH | Chief Executive Officer | Buy | — | — |
| 2024-10-24 | Roberto Cuca | COO and CFO | Buy | — | — |
| 2024-08-06 | Gregory A. Firestone | Chief Commercial Officer | F | — | — |
| 2024-07-02 | OrbiMed Capital GP IV LLC | 10%+ Owner | Sell | — | — |
| 2024-06-06 | DOUGLAS G EVANS | Director | A | — | — |
| 2024-06-06 | Kurt Azarbarzin | Director | A | — | — |
| 2024-06-06 | Federica F. O'Brien | Director | A | — | — |
| 2024-06-06 | LISA N COLLERAN | Director | A | — | — |
| 2024-06-06 | Jeffrey Blizard | Director | A | — | — |
| 2024-06-06 | Vincent J Burgess | Director | A | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | 10%+ Owner | 9,106,477 | — |
| — | 10%+ Owner | 5,485,084 | — |
| — | 10%+ Owner | 4,105,709 | — |
| — | — | 3,605,709 | — |
| — | 10%+ Owner | 3,580,709 | — |
| — | 10%+ Owner | 2,891,542 | — |
| — | Director | 1,751,100 | — |
| — | 10%+ Owner | 1,175,358 | — |
| — | 10%+ Owner | 1,139,358 | — |
| — | Director | 774,056 | — |
| — | Chief Executive Officer | 766,110 | — |
| — | Chief Executive Officer | 532,500 | — |
| — | Director | 505,281 | — |
| — | Director | 299,260 | — |
| — | Director | 280,790 | — |
| — | COO and CFO | 262,611 | — |
| — | President | 205,125 | — |
| — | Chief Technology Officer | 180,882 | — |
| — | Chief Business Officer | 139,307 | — |
| — | 10%+ Owner | 124,813 | — |
| — | Chief Medical Officer | 90,887 | — |
| — | Chief Accounting Officer | 69,681 | — |
| — | Chief Commercial Officer | 48,129 | — |
| — | Director | 44,530 | — |
| — | Director | 29,827 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the TELA quote page; the site-wide leaderboard is on the insider transactions hub.